The M1 metabolite of Nintedanib is a structurally related impurity derived from oxidative metabolism of the parent compound's pyridine-pyrimidine core. It retains the bicyclic scaffold but features a hydroxylated aromatic ring and a carboxylic acid moiety formed via phase I hepatic metabolism. This metabolite arises from electrophilic substitution at the 5-position of the pyrimidine ring, resulting in a polar, water-soluble degradation byproduct. Its precise application includes serving as an HPLC reference standard for quantifying process-related impurities in Nintedanib drug substance analysis.
On Request